Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer Bleeding
Clinical trial NCT06783257 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06783257
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2027-02-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.